In this issue:
Anti-PD-1 plus ATRA
Treatment of desmoplastic melanoma
Brain metastasis incidence to first-line treatments
ICI utilisation costs
NUM recurrence after functional surgery
Neoadjuvant treatment in the OpACIN trials
Patient acceptance of ICI treatment
PKC inhibitors in uveal melanoma
Radiotherapy and aneuploidy for non-small cell lung cancer
Radiotherapy after recurrences in stage III disease
T cell antigens in melanoma patients
Please login below to download this issue (PDF)